Fatty Liver Case Rounds Real-World Treatment Plans That Work

Fatty liver disease is increasingly recognized as a hepatic manifestation of systemic metabolic dysfunction, yet it remains underdiagnosed in everyday practice, often missed when standard liver enzymes fall within “normal” ranges.

This case-based session is designed to bridge the gap between recognition and action.

Using real-world patient scenarios, learners will develop a practical framework for identifying fatty liver risk earlier, interpreting key laboratory and fibrosis markers, and implementing stepwise, evidence-informed treatment strategies. The session emphasizes a clinically relevant approach that integrates lifestyle interventions, pharmacotherapy, and targeted adjunctive therapies without abandoning the realities of primary care practice.

Through guided case discussions, participants will explore common clinical presentations, including patients with metabolic risk but normal enzymes, those with type 2 diabetes and progressive liver involvement, and individuals at higher risk for fibrosis. The session will also highlight when to escalate care and how to co-manage patients effectively.

By the end of this session, clinicians will be better equipped to move beyond passive monitoring and toward proactive, structured management of fatty liver disease within the broader context of cardiometabolic health.

Target Audience

Healthcare professionals in primary care and cardiometabolic practice, including pharmacists, NPs, PAs, physicians, and nurses.

Learning Objectives

Identify metabolic risk patterns that should trigger MAFLD/MASH evaluation (even with “normal” liver enzymes). Interpret key liver health markers and fibrosis risk tools to stratify severity and urgency. Apply a stepwise, evidence-informed treatment approach integrating lifestyle therapy, pharmacotherapy, and targeted nutraceuticals when appropriate. Develop a monitoring plan (labs + imaging + follow-up intervals) and know when to refer.

Course summary
Available credit: 
  • 1.00 AANP
  • 1.00 AAPA Category 1 CME
  • 1.00 ACPE Pharmacist
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC

     

     

     

  • 1.00 Attendance
  • 1.00 CDR
Course opens: 
04/24/2026
Course expires: 
12/31/2026
Cost:
$0.00
Rating: 
0
04-24-2026-Live Webinar
United States
Reviewer(s)

Rebecca Lakofsky, BSN, RN

has no relevant financial relationships to disclose at this time.

Hannah Moore

has no relevant financial relationships to disclose at this time.

Megan Morrison

has no relevant financial relationships to disclose at this time.

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Revelar Health LLC. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

 

This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.

 

 

Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Pharmacists
AKH Inc., Advancing Knowledge in Healthcare designates this continuing education activity for 1.0  contact hours.

 

Nursing
Credit being awarded: 1.0 ANCC contact hours

 

 

 

Physician Associates
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

 

Nurse Practitioners
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and JP.  AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 1.0 contact hour(s) (which includes 0.0 hour(s) of pharmacology).

Dietitians


 

Available Credit

  • 1.00 AANP
  • 1.00 AAPA Category 1 CME
  • 1.00 ACPE Pharmacist
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC

     

     

     

  • 1.00 Attendance
  • 1.00 CDR

Price

Cost:
$0.00
Please login or register to take this course.